Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 6NETWORK 2

Study Type

Observational 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Lymphoma 9Breast Neoplasms 9Squamous Cell Carcinoma of Head and Neck 6Head and Neck Neoplasms 6Lymphoma, Follicular 5Neuroblastoma 4Central Nervous System Neoplasms 4Sarcoma 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Brain Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Salivary Gland Neoplasms 2Lymphoma, Large-Cell, Immunoblastic 2Lung Neoplasms 2Kidney Neoplasms 2Hodgkin Disease 2Gliosarcoma 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms, Male 2Wilms Tumor 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Teratoma 1Sarcoma, Kaposi 1Rhabdoid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1

Interventions

Cisplatin 4Paclitaxel 3Docetaxel 3Taxes 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Immunohistochemistry 2Gene Expression Profiling 2Gemcitabine 2Carboplatin 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1mercaptoundecahydrododecaborate 1bicalutamide 1Vorinostat 1Triptorelin Pamoate 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Pilocarpine 1Methotrexate 1Irinotecan 1In Situ Hybridization 1Erlotinib Hydrochloride 1Doxorubicin 1Chemotherapy, Adjuvant 1CP protocol 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 14-boronophenylalanine-fructose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Salivary Gland Neoplasms × Immunohistochemistry × Clear all
NCT01192750 2017-05-17

Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab

Eastern Cooperative Oncology Group

Completed
79 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT01487733 2017-05-17

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Eastern Cooperative Oncology Group

Completed
155 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡